T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.

BACKGROUND For early-stage breast cancer, the two current mainstay treatments are breast-conserving therapy (BCT; lumpectomy followed by radiotherapy [RT] and BCT) and mastectomy. Generally, triple-negative breast cancer (TNBC) is more aggressive compared to hormone receptor-positive breast cancer. We sought to investigate the effect of BCT compared to mastectomy on overall survival (OS) and breast cancer-specific survival (BCSS) in T1-2N0M0 TNBC. PATIENTS AND METHODS A population-based retrospective analysis was performed using the Surveillance, Epidemiology, and End Results (SEER) database. Patients included in the analysis were divided into 3 groups according to surgical modality and RT: BCT, mastectomy alone, and mastectomy with RT. The survival end points were OS and BCSS, and survival analysis was performed by the Kaplan-Meier method and the log-rank test among treatment types. RESULTS A total of 14,910 female subjects with T1-2N0M0 TNBC diagnosed between 2010 and 2014 were included. A total of 7381 patients had BCT; 6967 had mastectomy alone, and 562 had mastectomy with RT. Patients treated with BCT had better OS (log-rank P < .05) and BCSS (log-rank P < .05) than those receiving mastectomy with or without RT. The 5-year OS was 88.6% for BCT, 83.0% for mastectomy alone, and 79.6% for mastectomy with RT. The 5-year BCSS was 94.3% for BCT, 93.3% for mastectomy alone, and 83.7% for mastectomy with RT. CONCLUSION In patients with T1-2N0M0 TNBC, BCT was associated with superior OS and BCSS compared to mastectomy with or without RT. After mastectomy, there was no evidence of survival benefit of RT.

• Publication year

  2019

• Venue

  Clinical Breast Cancer

• Publication date

  2019-05-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CLBC.2019.05.011PMID 31375327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases

  2019cited by this paper
• Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies.

  2018cited by this paper
• Comparison of Treatment Outcomes With Breast‐conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score‐matched Analysis

  2018cited by this paper
• Breast conserving therapy and mastectomy revisited: Breast cancer‐specific survival and the influence of prognostic factors in 129,692 patients

  2017cited by this paper
• Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival.

  2017cited by this paper
• Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review

  2017cited by this paper
• The value of adjuvant radiotherapy on survival and recurrence in triple-negative breast cancer: A systematic review and meta-analysis of 5507 patients.

  2016cited by this paper
• Prognostic role of adjuvant radiotherapy in triple‐negative breast cancer: A historical cohort study

  2015cited by this paper
• Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based Stage-by-Stage Comparison.

  2015cited by this paper
• Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008

  2015cited by this paper
• Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy.

  2015cited by this paper
• Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy

  2015cited by this paper
• Radiation therapy in the locoregional treatment of triple-negative breast cancer.

  2015cited by this paper
• Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.

  2014cited by this paper
• Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death

  2013cited by this paper
• Breast-Conserving Therapy Achieves Locoregional Outcomes Comparable to Mastectomy in Women with T1-2N0 Triple-Negative Breast Cancer

  2013cited by this paper
• Twenty-five year results of the national cancer institute randomized breast conservation trial

  2012cited by this paper
• Triple-negative breast cancer: epidemiological considerations and recommendations.

  2012cited by this paper
• Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial.

  2011cited by this paper
• Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.

  2011cited by this paper
• Triple-negative breast cancer.

  2010cited by this paper
• Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

  2007cited by this paper
• Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation

  2003cited by this paper
• Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

  2002cited by this paper
• Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

  2002cited by this paper
• Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.

  2002cited by this paper

• Breast-Conserving Surgery vs Mastectomy for Non-metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Observational Studies

  2025cites this paper
• Comparing irradiated clinical outcomes between modified radical mastectomy and breast-conserving surgery in patients with pathologic stage III breast cancer: A national population-based match cohort study.

  2025cites this paper
• Treatment strategies for triple-negative primary breast cancer in older women: a systematic review

  2025cites this paper
• Log odds of positive lymph nodes as a prognostic marker in resectable triple negative breast cancer

  2025cites this paper
• Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage breast cancer: a propensity score matching analysis

  2024cites this paper
• Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis

  2024cites this paper
• Locoregional Management of Multiple Ipsilateral Breast Cancers: A Review.

  2024cites this paper
• YF343, a Novel Histone Deacetylase Inhibitor, Combined with CQ to Inhibit- Autophagy, Contributes to Increased Apoptosis in Triple-Negative Breast Cancer.

  2023cites this paper
• Breast-Conserving Surgery or Mastectomy?

  2022cites this paper
• Is breast conservation superior to mastectomy in early stage triple negative breast cancer?

  2022cites this paper
• Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy

  2022cites this paper
• Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients

  2022cites this paper
• β-elemene induced apoptosis and senescence of triple-negative breast cancer cells through IGF1/IGF1R pathway.

  2022cites this paper
• Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy

  2022cites this paper
• Does Mastectomy Reduce Overall Survival in Early Stage Breast Cancer?

  2021cites this paper
• Outcomes after breast-conserving surgery or mastectomy in patients with triple-negative breast cancer: meta-analysis.

  2021cites this paper
• Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer

  2021cites this paper
• Counterpoint: Does Mastectomy Reduce Overall Survival in Early Stage Breast Cancer?

  2021cites this paper
• Breast-Conserving Therapy Has Better Prognosis for Tumors in the Central and Nipple Portion of Breast Cancer Compared with Mastectomy: A SEER Data-Based Study

  2021cites this paper
• Breast conservation therapy confers survival and distant recurrence advantage over mastectomy for stage II Triple Negative Breast cancer.

  2020cites this paper
• 10-Year Survival after Breast-Conserving Surgery Compared with Mastectomy in Louisiana Women with Early-Stage Breast Cancer: A Population-Based Study.

  2020cites this paper
• Exploring the Regulation Mechanism of Xihuang Pill, Olibanum and β-Boswellic Acid on the Biomolecular Network of Triple-Negative Breast Cancer Based on Transcriptomics and Chemical Informatics Methodology

  2020cites this paper